Edition:
United Kingdom

Healthcare

GSK.L
AZN.L
SN.L

Deals of the day-Mergers and acquisitions

April 19 The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday: ** Japan's Takeda Pharmaceutical is in negotiations with Shire after making a third takeover bid worth around $61 billion that was rejected by the London-listed rare diseases drugmaker. ** Brazil's state-run oil company Petroleo Brasileiro SA is considering selling 60 percent stakes in two regional blocks comprising four refineries, and keeping full ownership of nine other units,

2:39pm BST

BRIEF-Boule Diagnostics Unit Buys New Technologies From Drew Scientific

* UNIT BOULE MEDICAL AB BUYS NEW TECHNOLOGIES FROM DREW SCIENTIFIC, INC.

2:35pm BST

BRIEF-Novartis AG CFO Says Q2 Core Operating Profit Growth To Be In Low To Mid Single Digits, Improvements To Come

* CFO SAYS Q2 CORE OPERATING PROFIT GROWTH TO BE IN LOW TO MID SINGLE DIGITS, FOLLOWED BY IMPROVEMENTS LATER IN YEAR

2:22pm BST

BRIEF-Namaste Receives Conditional Approval To List On TSX Venture Exchange

* NAMASTE RECEIVES CONDITIONAL APPROVAL TO LIST ON TSX VENTURE EXCHANGE Source text for Eikon: Further company coverage:

2:20pm BST

BRIEF-Sinovac Announces Preliminary Results Of Phase Iii Trial On Sipv

* SINOVAC ANNOUNCES PRELIMINARY RESULTS OF PHASE III TRIAL ON SIPV

2:19pm BST
Healthcare
GlaxoSmithKline PLC 1,414.80 -0.48%
AstraZeneca PLC 4,962.50 -0.04%
Smith & Nephew PLC 1,339.50 -0.04%

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.